Levothyroxine requirement in congenital hypothyroidism: a 12-year longitudinal study

Endocrine
Maurizio DelvecchioMaria Felicia Faienza

Abstract

The aim of the replacement therapy with levothyroxine in congenital hypothyroidism (CH) is to correct hypothyroidism and ensure normal growth and neuropsychological development. Few data are available about the appropriate dose during childhood and early adolescence; therefore, we performed a multicenter observational study in a large population of patients with CH to assess the required levothyroxine dose to obtain euthyroidism. We recruited 216 patients with permanent CH classified into three groups (agenesia, ectopia, and in situ gland) on the basis of the thyroid imaging. The levothyroxine dose was recorded at 6 and 12 months and then yearly until 12 years of age. The daily levothyroxine requirement progressively decreased during the follow-up, irrespective of etiology. It was significantly lower in patients with in situ gland than in patients with athyreosis during the entire study period and with ectopic gland from the age of 1 year. The levothyroxine requirement at 6 months of age was correlated with the requirement at each later time-point. The daily dose was modified less frequently in patients with in situ thyroid (36 %) than in patients with ectopic gland (41.4 %) or with athyreosis (43.6 %). Patients with in situ gl...Continue Reading

References

Aug 1, 1990·The Journal of Pediatrics·J A Germak, T P Foley
Jan 1, 1996·The Journal of Clinical Endocrinology and Metabolism·J M DubuisG Van Vliet
Apr 1, 1996·Journal of Endocrinological Investigation·V SiragusaG Chiumello
Jul 31, 1999·European Journal of Endocrinology·M SalernoA Tenore
Mar 7, 2001·The Journal of Clinical Endocrinology and Metabolism·A HanukogluD Daneman
Jan 5, 2002·Journal of Developmental and Behavioral Pediatrics : JDBP·S I SongJ Rovet
Feb 13, 2002·Thyroid : Official Journal of the American Thyroid Association·Mariacarolina SalernoAlfred Tenore
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Jun 3, 2006·Pediatrics·Susan R RoseSurendra K Varma
Oct 24, 2006·Clinical Endocrinology·Maurizio DelvecchioLuciano Cavallo
Jul 5, 2008·Clinical Endocrinology·Sarah MathaiPaul Hofman
Mar 11, 2011·The Journal of Clinical Endocrinology and Metabolism·Juliane LégerUNKNOWN French Congenital Hypothyroidism Study Group
Oct 7, 2011·The Journal of Clinical Endocrinology and Metabolism·Stephen H LaFranchi
Feb 20, 2013·Journal of Clinical Research in Pediatric Endocrinology·Pinar CengizRüveyde Bundak
Aug 28, 2013·The Journal of Clinical Endocrinology and Metabolism·Jacoba J Bongers-SchokkingSabine M P F de Muinck Keizer-Schrama
Jan 23, 2014·The Journal of Clinical Endocrinology and Metabolism·Juliane LégerUNKNOWN Congenital Hypothyroidism Consensus Conference Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.